Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes

Ana Palanca, Esmeralda Castelblanco, Hèctor Perpiñán, Àngels Betriu, Berta Soldevila, José Manuel Valdivielso, Marcelino Bermúdez, Xavier Duran, Elvira Fernández, Manel Puig-Domingo, Per Henrik Groop, Núria Alonso, Dídac Mauricio

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)

Abstract

© 2018 Elsevier B.V. Background and aims: Cardiovascular disease is the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD) and diabetes. Traditional cardiovascular risk factors fail to fully account for the increase in cardiovascular risk in these patients. This study aims to analyse the prevalence and progression of subclinical atherosclerosis in CKD patients with and without diabetes. Methods: We included data from CKD patients with and without diabetes free from previous cardiovascular events from the NEFRONA cohort. Patients underwent baseline and 24-month follow-up carotid and femoral ultrasound examinations. Multivariable models were used to assess the contribution of diabetes to the presence and plaque progression. Results: A total of 419 patients with diabetes and 1129 without diabetes were included. Diabetic patients were older, had higher BMIs, more hypertension and dyslipidaemia. At baseline, the proportion of patients with plaque was higher among diabetic patients (81.4% vs. 64.1%, p < 0.001). Diabetic patients more frequently had more than two vascular territories with plaque (64.4% vs. 48.4%, p < 0.001). Multivariable analysis indicated that plaque at baseline was significantly associated with age, gender, smoking and renal replacement therapy (RRT) in the non-diabetic patients, but only with age and male gender in diabetic patients. Plaque progression was significantly associated with age, number of territories with basal plaque, smoking and RRT in both groups. Conclusions: Subclinical atherosclerosis is more prevalent, carries a higher plaque burden and is more rapidly progressive in renal patients with diabetes. In these patients, diabetes outweighs other described risk factors associated with the presence of subclinical atherosclerosis.
Original languageEnglish
Pages (from-to)50-57
JournalAtherosclerosis
Volume276
DOIs
Publication statusPublished - 1 Sep 2018

Keywords

  • Cardiovascular outcomes
  • Chronic kidney disease
  • Diabetes
  • Subclinical atherosclerosis

Fingerprint Dive into the research topics of 'Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes'. Together they form a unique fingerprint.

Cite this